封面
市場調查報告書
商品編碼
1473793

介入性脊椎市場 - 按產品、應用、手術類型、最終用途 - 全球預測,2024 年 - 2032 年

Interventional Spine Market - By Product, Application, Surgery Type, End-use - Global Forecast, 2024 - 2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 320 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

由於微創技術的不斷進步以及對脊椎疾病有效疼痛管理解決方案的關注,2024 年至 2032 年全球介入性脊椎市場規模將錄得 4.8% 的複合年成長率。由於微創手術可以縮短恢復時間並減少術後疼痛,患者和醫療保健提供者擴大選擇這些方法。此外,機器人輔助手術等技術升級提高了脊椎手術的精確度和安全性。隨著對侵入性較小但有效的治療的需求的增加,介入脊椎產業將擴大以滿足這些不斷變化的需求。

例如,2022年11月,SeaSpine推出了7D FLASH導航系統的經皮脊椎模組,透過脊椎手術的精確引導來增強微創手術能力。

介入脊椎市場根據產品、手術類型、最終用途、應用和地區而分散。

到 2032 年,由於椎體壓迫性骨折盛行率上升,特別是在老年人口中,椎體壓迫性骨折治療領域將顯著激增。椎體成形術和椎體後凸成形術等治療方法為緩解疼痛和穩定骨折提供了微創且有效的解決方案。隨著人們越來越關注改善脊椎疾病患者的生活品質,椎體壓迫性骨折治療領域將繼續在介入性脊椎產業保持成長軌跡。

到 2032 年,在這些診所在診斷和治療脊椎相關疾病方面提供的專業護理和專業知識的推動下,專科診所部門將累積顯著的介入性脊椎市場佔有率。專科診所僅專注於脊椎治療,提供全面的護理,包括微創手術和復健服務。尋求脊椎疾病專門護理的患者擴大轉向這些診所,推動了市場的成長。憑藉專門的脊椎健康方法和一系列治療選擇,專科診所部門將保持其在介入脊椎市場的主導地位。

由於該地區完善的醫療基礎設施、對研發的高度重視以及先進醫療技術的高採用率,2024年至2032年歐洲介入脊椎產業將呈現出引人注目的複合年成長率。德國和英國等國家處於脊椎手術和創新治療的前沿。此外,老年人口中脊椎相關疾病的日益流行也促進了市場的成長。歐洲將重點關注以患者為中心的護理和獲得尖端治療,將成為介入脊椎行業的關鍵貢獻者,推動脊椎醫療保健的進步。

目錄

第 1 章:方法與範圍

第 2 章:執行摘要

第 3 章:產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 脊椎疾病盛行率上升
      • 微創手術的需求不斷增加
      • 技術進步
      • 用於開發更先進技術的公共和私人投資增加
    • 產業陷阱與挑戰
      • 脊椎手術費用高
      • 嚴格的監管場景
  • 成長潛力分析
  • 監管環境
  • 技術景觀
  • 波特的分析
  • PESTEL分析
  • 未來市場趨勢

第 4 章:競爭格局

  • 介紹
  • 公司矩陣分析
  • 公司市佔率分析
  • 競爭定位矩陣
  • 戰略儀表板

第 5 章:市場估計與預測:按產品分類,2018 年 - 2032 年

  • 主要趨勢
  • 胸椎融合器和腰椎融合器
    • 後胸椎融合器和腰椎融合器
    • 胸椎椎間融合器和腰椎椎間融合器
    • 前路胸椎融合器與腰椎融合器
  • 頸椎融合器
    • 頸椎前路融合器
    • 頸椎後路融合器
  • 椎體壓迫性骨折治療裝置
    • 球囊椎體後凸成形術裝置
    • 椎體成形術設備
  • 脊椎生物製劑
    • 去礦骨基質
    • 骨形態發生蛋白
    • 骨替代品
    • 機械加工骨頭
    • 基於細胞的矩陣
    • 同種異體骨
  • 脊椎減壓裝置
    • 椎間盤切除術
    • 椎板成形術、椎板切除術和椎板切開術
    • 椎間孔切開術和椎間孔切除術
    • 小關節面切除術
    • 椎體切除術
  • 非融合裝置
    • 動態穩定
    • 人工椎間盤置換
      • 人工頸椎間盤
      • 人工腰椎間盤
    • 環空修復裝置
    • 核椎間盤假體
  • 脊椎骨刺激器
    • 非侵入性脊椎骨刺激器
      • 脈衝電磁場裝置
      • 電容耦合 (CC) 裝置
      • 組合(電)磁場 (CMF) 設備
    • 侵入式脊椎骨刺激器

第 6 章:市場估計與預測:按應用分類,2018 年 - 2032 年

  • 主要趨勢
  • 脊椎融合與固定
  • 椎體壓迫性骨折治療
  • 運動保留/非融合
  • 脊椎減壓

第 7 章:市場估計與預測:按手術類型,2018 年 - 2032 年

  • 主要趨勢
  • 開放性手術
  • 微創手術

第 8 章:市場估計與預測:按最終用途,2018 - 2032 年

  • 主要趨勢
  • 醫院
  • 專科診所
  • 門診手術中心
  • 其他最終用戶

第 9 章:市場估計與預測:按地區分類,2018 年 - 2032 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區

第 10 章:公司簡介

  • Alphatec Holdings, Inc.
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • ChoiceSpine LLC
  • DePuy Synthes
  • Globus Medical, Inc.
  • Integra LifeSciences Corporation
  • Medtronic plc
  • Nuvasive, Inc.
  • Orthofix Medical Inc.
  • RTI Surgical
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
簡介目錄
Product Code: 8198

Global Interventional Spine Market Size will record a 4.8% CAGR between 2024 and 2032 due to continuous advancements in minimally invasive techniques and a focus on effective pain management solutions for spine conditions. With minimally invasive procedures offering reduced recovery times and less postoperative pain, patients and healthcare providers are increasingly opting for these approaches. Additionally, technological upgrades like robotic-assisted surgeries improve the precision and safety of spine procedures. As the demand for less invasive yet effective treatments rises, the interventional spine industry will expand to meet these evolving needs.

For instance, in November 2022, SeaSpine introduced the 7D FLASH navigation system's percutaneous spine module, enhancing minimally invasive surgical capabilities with precise guidance for spinal procedures.

The interventional spine market is fragmented based on product, surgery type, end-use, application, and region.

The vertebral compression fracture treatment segment will see a notable surge by 2032, attributed to the rising prevalence of vertebral compression fractures, particularly in aging populations. Treatments such as vertebroplasty and kyphoplasty offer minimally invasive and effective solutions for pain relief and fracture stabilization. With a growing focus on improving the quality of life for patients with spinal conditions, the vertebral compression fracture treatment segment will continue its growth trajectory in the interventional spine industry.

The specialty clinics segment will amass a remarkable interventional spine market share by 2032, driven by the specialized care and expertise offered by these clinics in diagnosing and treating spine-related disorders. Specialty clinics focus solely on spine treatments, providing comprehensive care that includes minimally invasive procedures and rehabilitation services. Patients seeking specialized care for spinal conditions are increasingly turning to these clinics, driving the market growth. With a dedicated approach to spine health and a range of treatment options, the specialty clinics segment will maintain its dominance in the interventional spine market.

Europe interventional spine industry will exhibit a noteworthy CAGR from 2024 to 2032, owing to the region's well-established healthcare infrastructure, strong emphasis on research and development, and high adoption rates of advanced medical technologies. Countries like Germany and the UK are at the forefront of spine surgeries and innovative treatments. Additionally, the growing prevalence of spine-related disorders in the aging population contributes to market growth. With a focus on patient-centric care and access to cutting-edge treatments, Europe will stand as a pivotal contributor to the interventional spine industry, shaping advancements in spinal healthcare.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Base estimates & calculations
  • 1.3 Data collection
  • 1.4 Forecast parameters
  • 1.5 Data validation
  • 1.6 Data sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

  • 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising prevalence of spinal diseases
      • 3.2.1.2 Increasing demand for minimally invasive procedures
      • 3.2.1.3 Technological advancements
      • 3.2.1.4 Rise in public and private investments for the development of more advanced technologies
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High cost of spinal surgeries
      • 3.2.2.2 Stringent regulatory scenario
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technological landscape
  • 3.6 Porter's analysis
    • 3.6.1 Supplier power
    • 3.6.2 Buyer power
    • 3.6.3 Threat of new entrants
    • 3.6.4 Threat of substitutes
    • 3.6.5 Industry rivalry
  • 3.7 PESTEL analysis
  • 3.8 Future market trends

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2018 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Thoracic fusion and lumbar fusion devices
    • 5.2.1 Posterior thoracic fusion and lumbar fusion devices
    • 5.2.2 Interbody thoracic fusion and lumbar fusion devices
    • 5.2.3 Anterior thoracic fusion and lumbar fusion devices
  • 5.3 Cervical fusion devices
    • 5.3.1 Anterior cervical fusion devices
    • 5.3.2 Posterior cervical fusion devices
  • 5.4 Vertebral compression fracture treatment devices
    • 5.4.1 Balloon kyphoplasty devices
    • 5.4.2 Vertebroplasty devices
  • 5.5 Spine biologics
    • 5.5.1 Demineralized bone matrix
    • 5.5.2 Bone morphogenetic proteins
    • 5.5.3 Bone substitutes
    • 5.5.4 Machined bones
    • 5.5.5 Cell-based matrices
    • 5.5.6 Allograft bone
  • 5.6 Spinal decompression devices
    • 5.6.1 Discectomy
    • 5.6.2 Laminoplasty, laminectomy, and laminotomy
    • 5.6.3 Foraminotomy & foraminectomy
    • 5.6.4 Facetectomy
    • 5.6.5 Corpectomy
  • 5.7 Non-fusion devices
    • 5.7.1 Dynamic stabilization
    • 5.7.2 Artificial discs replacement
      • 5.7.2.1 Artificial cervical disc
      • 5.7.2.2 Artificial lumbar disc
    • 5.7.3 Annulus repair devices
    • 5.7.4 Nuclear disc prostheses
  • 5.8 Spine bone stimulators
    • 5.8.1 Noninvasive spine bone stimulators
      • 5.8.1.1 Pulsed electromagnetic field devices
      • 5.8.1.2 Capacitive coupling (CC) devices
      • 5.8.1.3 Combined (electro) magnetic field (CMF) devices
    • 5.8.2 Invasive spine bone stimulators

Chapter 6 Market Estimates and Forecast, By Application, 2018 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Spinal fusion and fixation
  • 6.3 Vertebral compression fracture treatment
  • 6.4 Motion preservation/non-fusion
  • 6.5 Spinal decompression

Chapter 7 Market Estimates and Forecast, By Surgical Type, 2018 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Open surgeries
  • 7.3 Minimally invasive surgeries

Chapter 8 Market Estimates and Forecast, By End-use, 2018 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals
  • 8.3 Specialty clinics
  • 8.4 Ambulatory surgical centers
  • 8.5 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Italy
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
    • 9.5.4 Rest of Latin America
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE
    • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

  • 10.1 Alphatec Holdings, Inc.
  • 10.2 B. Braun Melsungen AG
  • 10.3 Boston Scientific Corporation
  • 10.4 ChoiceSpine LLC
  • 10.5 DePuy Synthes
  • 10.6 Globus Medical, Inc.
  • 10.7 Integra LifeSciences Corporation
  • 10.8 Medtronic plc
  • 10.9 Nuvasive, Inc.
  • 10.10 Orthofix Medical Inc.
  • 10.11 RTI Surgical
  • 10.12 Stryker Corporation
  • 10.13 Zimmer Biomet Holdings, Inc.